Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

UK Appeal Panel Tells NICE To Revisit Scenesse Rejection

Oct 12 2018

• By Ian Schofield

Think again! — NICE is to reconsider its recommendation on Clinuvel's Scenesse. • Source: Shutterstock

Related Content

Will NICE Change Its Mind On Scenesse After UK Public Hearing?

Sep 06 2018

Related Companies

Clinuvel Pharmaceuticals Limited

Additional Topics

United Kingdom Europe Health Technology Assessment Regulation Reimbursement Market Access BioPharmaceutical

More from Health Technology Assessment

More from Market Access

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.